National Cancer Institute Director W. Kimryn Rathmell, MD, PhD, spoke Monday at the Annual Meeting about the importance of innovative and engaging collaborations in the fight to end cancer as we know it.

Annual Meeting Program Chairs Keith T. Flaherty, MD, FAACR, and Christina Curtis, PhD, MSc, preview Wednesday’s program to help you plan your schedule for the final day at the Annual Meeting 2024.

Adetunji Toriola, MD, PhD, will chair a Wednesday morning session on the potential impact chemoprevention can have on reducing cancer burden.

Susan Bullman, PhD, discussed the tumor ecosystem during a Monday plenary session, focusing on the impact of intratumoral microbes on spatial and cellular heterogeneity in cancer.